EDAP TMS S.A. (FOCL) vs Hyperfine (HYPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
EDAP TMS S.A. (FOCL) has outperformed Hyperfine (HYPR) over the past year, gaining 90.5% versus a loss of 50.6%. Over five years, FOCL leads with a -30.7% price change compared with -91.5% for HYPR. EDAP TMS S.A. is the larger company by market cap ($199.0 million vs $92.8 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FOCL | HYPR |
|---|---|---|
| Share price | $4.22 | $0.8752 |
| Market cap | $199.02M | $92.81M |
| 1-day change | +0.60% | +3.09% |
| YTD return | +27.36% | -13.28% |
| 1-year return | +90.45% | -50.64% |
| 5-year return | -30.74% | -91.46% |
| EPS (TTM) | $-1.39 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.40 | $2.22 |
| 52-week low | $1.75 | $0.754 |
| Distance from 52-week high | -34.14% | -60.58% |
| Analyst consensus | buy | — |
| Avg. price target upside | +108.78% | — |
| Average volume | 115.24K | 611.89K |
| Shares outstanding | 47.22M | 90.99M |
| Employees | 289 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EDAP TMS S.A. is about 2.1 times larger than Hyperfine by market value ($199.02M vs $92.81M).
- FOCL has outperformed HYPR by 141.1 percentage points over the past year.
About EDAP TMS S.A.
FOCL stock →EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees
FOCL vs HYPR FAQ
Which is bigger, EDAP TMS S.A. or Hyperfine?
EDAP TMS S.A. (FOCL) is larger, with a market capitalization of $199.02M compared with $92.81M for Hyperfine (HYPR).
Which stock has performed better over the past year, FOCL or HYPR?
FOCL returned +90.45% over the past 12 months, compared with -50.64% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are EDAP TMS S.A. and Hyperfine in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.